Polaryx Therapeutics, Inc. Common Stock

NASDAQ:PLYX

Biotechnology

Healthcare
$1.61 -0.87%

-$0.02 today

Market cap
$80.25M
Beta
0.00
P/E (TTM)
-16.7
EPS (TTM)
-$0.14
52W Low $2.01High $48.91

Volume 0.02M

Average 0.34M

PLYX Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

No reported Net Margin figures are available to summarize.

Net Margin history

Percent of revenue · from the income statement

No Net Margin data reported for this period type.

Net Margin vs competitors

How PLYX compares with its peers on the latest reported figures

PLYX Competitors Peer median
Net Margin for PLYX and competitors
Company Period LTM level YoY 3-year change
PTHSPelthos Therapeutics Inc.LTM Mar 2026-186.2% ——
FHTXFoghorn Therapeutics Inc.LTM Mar 2026-266.9% +75.4 pp+325.9 pp
CBIOCrescent Biopharma, Inc.LTM Mar 2026-1363.9% —+60832.1 pp
LYELLyell Immunopharma, Inc.LTM Mar 2026-794858.1% -280208.8 pp-762139.3 pp
PLYXPolaryx Therapeutics, Inc. Common StockFY2025— ——
JBIOJade Biosciences, Inc.FY2025— ——
ANTXAN2 Therapeutics, Inc.FY2025— ——
KLRSKalaris Therapeutics IncFY2025— ——
Peer median (excluding PLYX) -815.4%-140066.7 pp+325.9 pp

Competitors are the stored peer set for PLYX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue000
Cost of Revenue000
Gross Profit000
Gross Margin———
Research & Development2.77M2.81M6.27M
Selling, General & Admin1.01M1.54M1.56M
Operating Expenses3.78M4.35M7.82M
Depreciation & Amortization000
EBITDA(3.78M)(30.36M)(8.99M)
EBITDA Margin———
Operating Income(3.78M)(4.35M)(7.82M)
Operating Margin———
Interest Income000
Interest Expense000
Other Income / Expenses2K(26M)(1.16M)
Income Before Tax(3.78M)(30.36M)(8.99M)
Pre-Tax Margin———
Income Tax Expense000
Net Income(3.78M)(30.36M)(8.99M)
Net Margin———
EPS (Basic)(0.02)(0.16)(0.19)
EPS (Diluted)(0.02)(0.16)(0.19)
Weighted Avg Shares189.37M189.37M47.34M
Weighted Avg Shares (Diluted)189.37M189.37M47.34M

Polaryx Therapeutics, Inc. Common Stock

NASDAQ:PLYX

Intrinsic Alpha fair value

Locked

Current Price

$1.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.